Trust Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Trust Investment Advisors's BMY Position: Q1 2021 in Review
Trust Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 10,344 shares — an estimated $642K sold.
Trust Investment Advisors first reported a position in BMY in Q4 2013 and held it in 25 quarters. The position peaked at $1.26M in Q1 2015. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Trust Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- Trust Investment Advisors sold 10,344 Bristol-Myers Squibb shares in Q1 2021, an estimated $642K.
- Trust Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 25 quarters.
- Trust Investment Advisors's Bristol-Myers Squibb position peaked at $1.26M in Q1 2015.
- 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Trust Investment Advisors's 13F filing for Q1 2021, filed 6 May 2021.